Mr William Alan Cohen, CRNA | |
3901 Rainbow Blvd, Kansas City, KS 66160-8500 | |
(913) 588-6670 | |
Not Available |
Full Name | Mr William Alan Cohen |
---|---|
Gender | Male |
Speciality | Certified Registered Nurse Anesthetist (crna) |
Experience | 6 Years |
Location | 3901 Rainbow Blvd, Kansas City, Kansas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578044988 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367500000X | Nurse Anesthetist, Certified Registered | 2019012963 (Missouri) | Secondary |
367500000X | Nurse Anesthetist, Certified Registered | 145775 (Kansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
North Kansas City Hospital | North kansas city, MO | Hospital |
Doctors Hospital Llc | Leawood, KS | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Saint Lukes Physician Group Inc | 3577476894 | 1070 |
Ascentist Physicians Group Llc | 9335143759 | 107 |
Saint Lukes Physician Group Inc | 3577476894 | 1070 |
Meritas Health Corporation | 6305748153 | 365 |
Ascentist Physicians Group Llc | 9335143759 | 107 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Midwest Anesthesia Associates, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336192392 PECOS PAC ID: 4981597838 Enrollment ID: O20040204000690 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Kansas University Physicians, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Saint Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20050302000266 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Anesthesia Associates Of Kansas City Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174504732 PECOS PAC ID: 1951206168 Enrollment ID: O20050721001069 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Ascentist Physicians Group Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1649206319 PECOS PAC ID: 9335143759 Enrollment ID: O20060829000434 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Entity Name | Gasgas Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104139534 PECOS PAC ID: 3870786544 Enrollment ID: O20101026000997 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Mr William Alan Cohen, CRNA 19 Hathaway Ct, Marlton, NJ 08053-5576 Ph: () - | Mr William Alan Cohen, CRNA 3901 Rainbow Blvd, Kansas City, KS 66160-8500 Ph: (913) 588-6670 |
News Archive
House Republicans are considering linking their support for raising the national debt to a repeal of the health law's risk corridors, which helps mitigate risk for insurers. In other news, lawmakers continue to weigh proposals to change how Medicare pays doctors and the House health appropriations subcommittee gets many new Republican faces.
Professor David Levine from the University of California, Berkeley, says a study of people in Spain and Italy has provided a "shred of evidence" that the BCG vaccination may protect against coronavirus disease 2019 (COVID-19).
In this post in USAID's "IMPACTblog," Anita Malley, internal displacement and protection adviser at the Office of U.S. Foreign Disaster Assistance, examines the importance of addressing sexual violence in conflicts and disasters, recapping a trip she took to Cote d'Ivoire with her colleagues in June.
"If any public health message has alarmed Americans in recent weeks, it is the repeated claim in the media that healthy young people are dying of 2009 H1N1, or swine flu. ... The response has been predictable: frantic parents clogging waiting rooms in pediatricians' offices, lining up for hours to get their kids vaccinated, and rushing to fill prescriptions for anti-viral drugs before the local pharmacy runs out" (11/17).
Roche (SIX: ROG.VX; RO.S, OTCQX: RHHBY) and InterMune, Inc. (Nasdaq: ITMN) today announced that the first patient has been dosed in a Phase 2b study evaluating the hepatitis C virus (HCV) protease inhibitor, RG7227/ ITMN-191, in combination with PEGASYS(R) (pegylated interferon alfa-2a) and COPEGUS(R) (ribavirin). The study, to be conducted at 45 sites globally, will further define the safety and efficacy profile of RG7227/ ITMN-191, for a treatment duration of up to 24 weeks. Approximately 300 treatment-naive patients chronically infected with HCV genotype 1 - the most difficult to treat form of the virus - will participate.
› Verified 6 days ago
Mrs. Michelle Renee Altenhofen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Nicki L Hamilton, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6670 Fax: 212-263-0664 | |
Renee L Mauer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-6670 Fax: 913-588-3365 | |
Morgan Bassi, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3901 Rainbow Blvd, Kansas City, KS 66160 Phone: 913-588-5000 | |
Kami Lynn Craigg, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1227 | |
John Wade Fogarty, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-588-1200 | |
Trevor Mason, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4000 Cambridge St, Kansas City, KS 66160 Phone: 913-424-2635 |